Drug intelligence / Profile preview

Chenxiang Huaqi Capsules

Development stage: Unknown
Lead developer: Huqing Yutang
Modality: Small Molecules
Administration: Oral

Overview

Chenxiang Huaqi Capsules (沉香化气胶囊) is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Hangzhou Huqingyutang Pharmaceutical. It is composed of several herbal ingredients, including Aquilaria, Aucklandia, Pogostemon, and Cyperus, which work synergistically to regulate qi, soothe the liver, and harmonize the stomach. The drug is primarily indicated for liver-stomach qi stagnation, which manifests as epigastric and abdominal distension, pain, poor appetite, belching, and acid regurgitation. As a traditional herbal product, it lacks a specific molecular target and is classified as an over-the-counter (OTC) medication in China.

Brand names: Huqingyutang
Other names: 沉香化气胶囊Chenxiang Huaqi Jiaonang

Beyond the preview

Go deeper on Chenxiang Huaqi Capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chenxiang Huaqi Capsules.

Explore the full profile